TY  - GEN
AU  - Alvarez, R
AU  - Musteanu, M
AU  - Garcia-Garcia, E
AU  - Lopez-Casas, P P
AU  - Megias, D
AU  - Guerra, Carmen::1131::600
AU  - Tabernero, S
AU  - Mu�oz, M
AU  - Quijano, Y
AU  - Cubillo, A
AU  - Rodriguez-Pascual, J
AU  - Plaza, C
AU  - de Vicente, E
AU  - Prados, S
AU  - Barbacid, Mariano::2355::600
AU  - Lopez-Rios, F
AU  - Hidalgo, M
PY  - 2013
DO  - 10.1038/bjc.2013.415
UR  - https://hdl.handle.net/20.500.12105/23069
AB  - BACKGROUND: Nab-paclitaxel and gemcitabine have demonstrated a survival benefit over gemcitabine alone in advanced pancreatic cancer (PDA). This study aimed to investigate the clinical, biological, and imaging effects of the regimen in patients with...
LA  - eng
PB  - Nature Publishing Group
KW  - Adenocarcinoma
KW  - Adult
KW  - Aged
TI  - Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.
TY  - research article
ER  -